EVERY TWO MINUTES SOMEONE IN THE U-S DIES FROM A NEUROLOGICAL EMERGENCY.
IN FACT, SEIZURES ARE ONE OF THE MOST COMMON REASONS FOR AMBULANCE RUNS.
NOW A NEW SIMPLE DEVICE COULD HELP SAVE TIME AND LIVES.
SEIZURES COME ON SUDDENLY AFFECTING ONE IN 100 PEOPLE OR TWO-POINT-FIVE MILLION AMERICANS. DELMETRIA GRANT IS ONE OF THEM. SHE BEGAN HAVING SEIZURES MORE THAN A DECADE AGO.
"It's frightening because you don't know what's going to happen, when it's going to happen."
WHILE MOST DON'T LAST LONGER THAN A MINUTE, THOSE WITH PROLONGED SEIZURES RISK BRAIN DAMAGE AND DEATH.
"So we know that the faster we can administer some treatment for them, the more likely that person is to stop seizing and to recover from that." DOCTOR TRICIA TING SAYS THE CURRENT STANDARD OF CARE FOR PATIENTS IS THROUGH AN I-V.
"But you can imagine how difficult it is when they are trying to access an IV in someone that may be convulsing and moving their arm around."
THAT'S WHY THE DOCTOR AND HER TEAM AT THE UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE PARTICIPATED IN A NATIONAL TRIAL TO TEST THIS NEW AUTO-INJECTOR.
("If you're trying to help someone you would take the cap off and then press this against the muscle and hold it there.")
IT'S SIMILAR TO THE EPI-PEN USED TO TREAT SERIOUS ALLERGIC REACTIONS. RESULTS FROM THE NATIONAL INSTITUTES OF HEALTH STUDY SHOW 73-PERCENT OF PATIENTS WHO RECEIVED INJECTED SEIZURE MEDICINE WERE SEIZURE-FREE WHEN THEY GOT TO THE HOSPITAL VERSUS 63-PERCENT OF PATIENTS WHO RECEIVED I-V TREATMENT.
"This is a proven therapy to work to stop seizures that are prolonged and dangerous."
NOW DOCTOR TING SAYS IT'S ONLY A MATTER OF TIME BEFORE THE AUTO-INJECTORS ARE IN THE HANDS OF PATIENTS AND THEIR FAMILIES TO STOP SEIZURES EVEN SOONER.
ABOUT 55-THOUSAND DEATHS ARE ATTRIBUTED TO PROLONGED SEIZURES.
WHILE IT MIGHT TAKE A WHILE UNTIL AN AUTO-INJECTOR "EPI-PEN" IS APPROVED FOR CAREGIVERS, PARAMEDICS CAN USE THE AUTO-INJECTOR RIGHT NOW.
Dentistry from the Heart gets underway at 7:30 Friday morning.
Banner Health in Phoenix is starting the first phase of a clinical…